JP2007506749A5 - - Google Patents

Download PDF

Info

Publication number
JP2007506749A5
JP2007506749A5 JP2006528111A JP2006528111A JP2007506749A5 JP 2007506749 A5 JP2007506749 A5 JP 2007506749A5 JP 2006528111 A JP2006528111 A JP 2006528111A JP 2006528111 A JP2006528111 A JP 2006528111A JP 2007506749 A5 JP2007506749 A5 JP 2007506749A5
Authority
JP
Japan
Prior art keywords
oxo
dihydroisoquinoline
carbonitrile
methoxy
fluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006528111A
Other languages
English (en)
Japanese (ja)
Other versions
JP4824563B2 (ja
JP2007506749A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/030945 external-priority patent/WO2005030729A1/en
Publication of JP2007506749A publication Critical patent/JP2007506749A/ja
Publication of JP2007506749A5 publication Critical patent/JP2007506749A5/ja
Application granted granted Critical
Publication of JP4824563B2 publication Critical patent/JP4824563B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006528111A 2003-09-23 2004-09-22 イソキノリンカリウムチャネル阻害剤 Expired - Fee Related JP4824563B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50521603P 2003-09-23 2003-09-23
US60/505,216 2003-09-23
PCT/US2004/030945 WO2005030729A1 (en) 2003-09-23 2004-09-22 Isoquinoline potassium channel inhibitors

Publications (3)

Publication Number Publication Date
JP2007506749A JP2007506749A (ja) 2007-03-22
JP2007506749A5 true JP2007506749A5 (cg-RX-API-DMAC7.html) 2007-09-06
JP4824563B2 JP4824563B2 (ja) 2011-11-30

Family

ID=34392992

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006528111A Expired - Fee Related JP4824563B2 (ja) 2003-09-23 2004-09-22 イソキノリンカリウムチャネル阻害剤

Country Status (7)

Country Link
US (1) US7763614B2 (cg-RX-API-DMAC7.html)
EP (1) EP1667981A4 (cg-RX-API-DMAC7.html)
JP (1) JP4824563B2 (cg-RX-API-DMAC7.html)
CN (1) CN1856477A (cg-RX-API-DMAC7.html)
AU (1) AU2004276268B2 (cg-RX-API-DMAC7.html)
CA (1) CA2539546C (cg-RX-API-DMAC7.html)
WO (1) WO2005030729A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1667976B1 (en) * 2003-09-23 2010-08-04 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
AU2004276236B2 (en) * 2003-09-23 2008-01-24 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
AU2004276267B2 (en) * 2003-09-23 2010-08-19 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
CA2539853C (en) * 2003-09-23 2011-04-19 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
WO2006015159A2 (en) 2004-07-29 2006-02-09 Merck & Co., Inc. Potassium channel inhibitors
EP1922311A2 (en) 2005-09-09 2008-05-21 Brystol-Myers Squibb Company Acyclic ikur inhibitors
KR101682058B1 (ko) * 2008-12-11 2016-12-02 비이브 헬쓰케어 컴퍼니 카르바모일피리돈 hiv 인테그라제 억제제를 위한 제조방법 및 중간체
EP2373163B1 (en) * 2008-12-19 2015-06-10 Genentech, Inc. Heterocyclic compounds and methods of use
GB0909671D0 (en) * 2009-06-04 2009-07-22 Xention Discovery Ltd Compounds
GB0909672D0 (en) * 2009-06-04 2009-07-22 Xention Discovery Ltd Compounds
US8940737B2 (en) 2011-10-14 2015-01-27 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
CN103987711B (zh) 2011-10-14 2016-08-24 艾伯维公司 作为用于治疗癌症和免疫性和自身免疫性疾病的凋亡诱导剂的8-氨基甲酰基-2-(2,3-二取代吡啶-6-基)-1,2,3,4-四氢异喹啉衍生物
CN103922952A (zh) * 2014-05-07 2014-07-16 宁夏宝马药业有限公司 用羟基乙腈制取环丙基甘氨酸的方法
AR104259A1 (es) 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
US9957267B2 (en) 2015-07-01 2018-05-01 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
IL291867A (en) * 2019-10-07 2022-06-01 De Shaw Res Llc Heterocyclic aryl compounds as Shaker kv1.3 potassium channel blockers
KR20220079878A (ko) * 2019-10-07 2022-06-14 디.이. 쇼우 리서치, 엘엘씨 Kv1.3 칼륨 셰이커 채널 차단제로서의 아릴 헤테로비시클릭 화합물
CN116693456A (zh) * 2022-02-28 2023-09-05 复旦大学 异喹啉酮类化合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287032C (cg-RX-API-DMAC7.html)
DD287032A5 (de) * 1989-07-28 1991-02-14 Karl-Marx-Universitaet Leipzig,De Verfahren zur herstellung von 3-carbamoyl-4-aryl-1,2-di-hydro-isochinolin-1h-onen
TW241258B (cg-RX-API-DMAC7.html) * 1992-04-15 1995-02-21 Takeda Pharm Industry Co Ltd
NO179904C (no) * 1992-09-04 1997-01-08 Takeda Chemical Industries Ltd Kondenserte heterocykliske forbindelser og deres anvendelse
WO2002024655A1 (en) * 2000-09-20 2002-03-28 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
BR0206831A (pt) 2001-02-02 2004-07-06 Takeda Chemical Industries Ltd Composto, cristal, agente farmacêutico, agentes para profilaxia ou tratamento de diabetes, de complicações diabéticas, de tolerância prejudicada à glucose e de obesidade, inibidor de peptidase, uso de um composto, e, método de produção de um composto
AU2004276236B2 (en) * 2003-09-23 2008-01-24 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
CA2539853C (en) * 2003-09-23 2011-04-19 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
EP1667976B1 (en) * 2003-09-23 2010-08-04 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
AU2004276267B2 (en) * 2003-09-23 2010-08-19 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors

Similar Documents

Publication Publication Date Title
JP2007506749A5 (cg-RX-API-DMAC7.html)
CA2539546A1 (en) Isoquinoline potassium channel inhibitors
US6998407B2 (en) Antagonists of MCP-1 function and methods of use thereof
CA2426440A1 (en) Quinazoline derivatives as kinase inhibitors
ES2254653T3 (es) Antagonistas de la funcion de mcp-1 y metodo de uso de los mismos.
JP2004527503A5 (cg-RX-API-DMAC7.html)
RU2312105C9 (ru) N-пиразинилфенилсульфонамиды и их применение при лечении опосредованных хемокинами заболеваний
KR100802332B1 (ko) 신규한 3-치환된 요소 유도체 및 그의 의학적 용도
RU2013133800A (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
HRP20041005A2 (en) Quinoline and isoquinoline derivatives, method forthe production thereof and use thereof as anti-inflammatory agents
TWI465439B (zh) 三氮唑衍生物或其鹽
JP2015517981A5 (cg-RX-API-DMAC7.html)
JP2010501587A5 (cg-RX-API-DMAC7.html)
RU2005137403A (ru) Новые замещенные 3-сера-индолы
RU2009148304A (ru) Модуляторы гидролазы амидов жирных кислот на основе гетероарилзамещенной мочевины
JP2010513304A5 (cg-RX-API-DMAC7.html)
JP2008507532A5 (cg-RX-API-DMAC7.html)
JP2013545798A5 (cg-RX-API-DMAC7.html)
RU2004127925A (ru) N3-алкилированные бензимидазольные производные в качестве ингибиторов мек
JP2005538955A5 (cg-RX-API-DMAC7.html)
JP2013517283A5 (cg-RX-API-DMAC7.html)
JP2004524301A5 (cg-RX-API-DMAC7.html)
CA2539853A1 (en) Isoquinolinone potassium channel inhibitors
KR20090039722A (ko) 부정맥의 치료를 위한 이소인돌린 유도체
EP1667989A1 (en) Substituted isoquinolinones